Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 1201 AL 1215

Will Europe be ready for the treatment of Alzheimer's disease?

The Lancet Neurology.

Lancet Neurol. 2018 Dec;17(12):1025. doi: 10.1016/S1474-4422(18)30409-5. Epub 2018 Nov 13.

Effects of Light Treatment on Sleep, Cognition, Mood, and Behavior in Alzheimer's Disease: A Systematic Review

Mitolo M, Tonon C, La Morgia C, Testa C, Carelli V, Lodi R.

Dement Geriatr Cogn Disord. 2018;46(5-6):371-384. doi: 10.1159/000494921. Epub 2018 Dec 11.

Status of Noninvasive Brain Stimulation in the Therapy of Alzheimer's Disease

Lin YC, Wang YP.

Chin Med J (Engl). 2018 Dec 20;131(24):2899-2903. doi: 10.4103/0366-6999.247217.

Advances in developing novel therapeutic strategies for Alzheimer's disease

Cao J, Hou J, Ping J, Cai D.

Mol Neurodegener. 2018 Dec 12;13(1):64. doi: 10.1186/s13024-018-0299-8.

Molecular and Functional Interaction of the Myokine Irisin with Physical Exercise and Alzheimer's Disease

Jin Y, Sumsuzzman DM, Choi J, Kang H, Lee SR, Hong Y.

Molecules. 2018 Dec 7;23(12):3229. doi: 10.3390/molecules23123229.

Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype

Pluta R, Ułamek-Kozioł M, Czuczwar SJ.

Int J Mol Sci. 2018 Dec 12;19(12):4002. doi: 10.3390/ijms19124002.

Biological clocks, some clock-related diseases, and medicinal plants

Deng TS.

Psych J. 2018 Dec;7(4):197-205. doi: 10.1002/pchj.263.

Atypical PKC: therapeutic target for Alzheimer's?

Farese RV, Sajan MP.

Aging (Albany NY). 2018 Dec 20;11(1):13-14. doi: 10.18632/aging.101730.

Liposome delivery systems for the treatment of Alzheimer's disease

Ross C, Taylor M, Fullwood N, Allsop D.

Int J Nanomedicine. 2018 Dec 12;13:8507-8522. doi: 10.2147/IJN.S183117. eCollection 2018.

Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials

Dou KX, Tan MS, Tan CC, Cao XP, Hou XH, Guo QH, Tan L, Mok V, Yu JT.

Alzheimers Res Ther. 2018 Dec 27;10(1):126. doi: 10.1186/s13195-018-0457-9.

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis

Kennedy RE, Cutter GR, Fowler ME, Schneider LS.

JAMA Netw Open. 2018 Nov 2;1(7):e184080. doi: 10.1001/jamanetworkopen.2018.4080.

Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation

Qazi TJ, Quan Z, Mir A, Qing H.

Mol Neurobiol. 2018 Feb;55(2):1026-1044. doi: 10.1007/s12035-016-0357-6. Epub 2017 Jan 14.

Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis

Zoltowska KM, Berezovska O.

Mol Neurobiol. 2018 Mar;55(3):2275-2284. doi: 10.1007/s12035-017-0487-5. Epub 2017 Mar 22.

Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease

Condello C, Stöehr J.

Neurobiol Dis. 2018 Jan;109(Pt B):191-200. doi: 10.1016/j.nbd.2017.03.014. Epub 2017 Mar 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias